Value Added Technology Co., Ltd.

KOSDAQ:A043150 Stock Report

Market Cap: ₩289.7b

Value Added Technology Valuation

Is A043150 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A043150 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A043150 (₩19840) is trading below our estimate of fair value (₩97336.58)

Significantly Below Fair Value: A043150 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for A043150?

Key metric: As A043150 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for A043150. This is calculated by dividing A043150's market cap by their current earnings.
What is A043150's PE Ratio?
PE Ratio7x
Earnings₩42.02b
Market Cap₩289.66b

Price to Earnings Ratio vs Peers

How does A043150's PE Ratio compare to its peers?

The above table shows the PE ratio for A043150 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average11.9x
A041830 InBodyLtd
8.6x21.8%₩268.0b
A100120 Vieworks
10.9x27.7%₩182.3b
A206640 Boditech Med
12.9x21.1%₩345.9b
A336570 WON TECHLtd
15x45.0%₩344.8b
A043150 Value Added Technology
7x18.5%₩289.7b

Price-To-Earnings vs Peers: A043150 is good value based on its Price-To-Earnings Ratio (7x) compared to the peer average (11.9x).


Price to Earnings Ratio vs Industry

How does A043150's PE Ratio compare vs other companies in the KR Medical Equipment Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
A035610 Solborn
2.5xn/aUS$64.77m
No more companies available in this PE range
A043150 7.0xIndustry Avg. 12.1xNo. of Companies8PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: A043150 is good value based on its Price-To-Earnings Ratio (7x) compared to the KR Medical Equipment industry average (12.1x).


Price to Earnings Ratio vs Fair Ratio

What is A043150's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A043150 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio7x
Fair PE Ratio13.1x

Price-To-Earnings vs Fair Ratio: A043150 is good value based on its Price-To-Earnings Ratio (7x) compared to the estimated Fair Price-To-Earnings Ratio (13.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst A043150 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₩19,840.00
₩33,166.67
+67.2%
9.1%₩38,000.00₩30,000.00n/a6
Dec ’25₩20,400.00
₩33,166.67
+62.6%
9.1%₩38,000.00₩30,000.00n/a6
Nov ’25₩22,850.00
₩37,833.33
+65.6%
8.6%₩44,000.00₩35,000.00n/a6
Oct ’25₩24,150.00
₩37,833.33
+56.7%
8.6%₩44,000.00₩35,000.00n/a6
Sep ’25₩24,000.00
₩38,571.43
+60.7%
9.1%₩44,000.00₩35,000.00n/a7
Aug ’25₩26,050.00
₩44,142.86
+69.5%
4.4%₩46,000.00₩40,000.00n/a7
Jul ’25₩27,000.00
₩44,142.86
+63.5%
4.4%₩46,000.00₩40,000.00n/a7
Jun ’25₩26,700.00
₩44,142.86
+65.3%
4.4%₩46,000.00₩40,000.00n/a7
May ’25₩29,450.00
₩44,142.86
+49.9%
4.4%₩46,000.00₩40,000.00n/a7
Apr ’25₩31,300.00
₩44,142.86
+41.0%
4.4%₩46,000.00₩40,000.00n/a7
Mar ’25₩30,400.00
₩44,142.86
+45.2%
4.4%₩46,000.00₩40,000.00n/a7
Feb ’25₩31,900.00
₩45,857.14
+43.8%
7.0%₩50,000.00₩40,000.00n/a7
Jan ’25₩33,250.00
₩45,571.43
+37.1%
7.2%₩50,000.00₩40,000.00n/a7
Dec ’24₩31,700.00
₩45,571.43
+43.8%
7.2%₩50,000.00₩40,000.00₩20,400.007
Nov ’24₩29,600.00
₩49,000.00
+65.5%
3.7%₩50,000.00₩45,000.00₩22,850.006
Oct ’24₩32,050.00
₩49,000.00
+52.9%
3.7%₩50,000.00₩45,000.00₩24,150.006
Sep ’24₩35,700.00
₩49,000.00
+37.3%
3.7%₩50,000.00₩45,000.00₩24,000.006
Aug ’24₩35,500.00
₩48,800.00
+37.5%
4.0%₩50,000.00₩45,000.00₩26,050.005
Jul ’24₩32,900.00
₩48,366.67
+47.0%
4.2%₩50,000.00₩45,000.00₩27,000.006
Jun ’24₩34,900.00
₩48,366.67
+38.6%
4.2%₩50,000.00₩45,000.00₩26,700.006
May ’24₩38,500.00
₩47,366.67
+23.0%
5.1%₩50,000.00₩44,000.00₩29,450.006
Apr ’24₩32,500.00
₩47,366.67
+45.7%
5.1%₩50,000.00₩44,000.00₩31,300.006
Mar ’24₩32,500.00
₩47,366.67
+45.7%
5.1%₩50,000.00₩44,000.00₩30,400.006
Feb ’24₩35,450.00
₩48,840.00
+37.8%
11.9%₩60,000.00₩44,000.00₩31,900.005
Jan ’24₩32,800.00
₩49,640.00
+51.3%
12.2%₩60,000.00₩44,000.00₩33,250.005
Dec ’23₩32,050.00
₩50,500.00
+57.6%
12.9%₩60,000.00₩44,000.00₩31,700.004

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies